JP2022547401A5 - - Google Patents
Info
- Publication number
- JP2022547401A5 JP2022547401A5 JP2022507861A JP2022507861A JP2022547401A5 JP 2022547401 A5 JP2022547401 A5 JP 2022547401A5 JP 2022507861 A JP2022507861 A JP 2022507861A JP 2022507861 A JP2022507861 A JP 2022507861A JP 2022547401 A5 JP2022547401 A5 JP 2022547401A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- eye
- affected
- symptoms
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026036757A JP2026090631A (ja) | 2019-09-10 | 2026-03-09 | 翼状片に関連した眼の見た目についての心配を軽減するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962898401P | 2019-09-10 | 2019-09-10 | |
| US62/898,401 | 2019-09-10 | ||
| PCT/US2020/050150 WO2021050692A2 (en) | 2019-09-10 | 2020-09-10 | Methods for alleviating pterygium-associated worry about eye appearance |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026036757A Division JP2026090631A (ja) | 2019-09-10 | 2026-03-09 | 翼状片に関連した眼の見た目についての心配を軽減するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022547401A JP2022547401A (ja) | 2022-11-14 |
| JP2022547401A5 true JP2022547401A5 (enExample) | 2023-09-19 |
Family
ID=74870040
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022507861A Pending JP2022547401A (ja) | 2019-09-10 | 2020-09-10 | 翼状片に関連した眼の見た目についての心配を軽減するための方法 |
| JP2026036757A Pending JP2026090631A (ja) | 2019-09-10 | 2026-03-09 | 翼状片に関連した眼の見た目についての心配を軽減するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026036757A Pending JP2026090631A (ja) | 2019-09-10 | 2026-03-09 | 翼状片に関連した眼の見た目についての心配を軽減するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220331310A1 (enExample) |
| EP (1) | EP4027997A4 (enExample) |
| JP (2) | JP2022547401A (enExample) |
| KR (1) | KR20220061147A (enExample) |
| CN (1) | CN114340618A (enExample) |
| AU (2) | AU2020346812A1 (enExample) |
| BR (1) | BR112021026662A2 (enExample) |
| CA (1) | CA3146811A1 (enExample) |
| MX (1) | MX2022000468A (enExample) |
| WO (1) | WO2021050692A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108135737B (zh) | 2015-06-06 | 2021-11-05 | 拨云生物医药科技(广州)有限公司 | 用于治疗翼状胬肉的组合物和方法 |
| BR112018074450A2 (pt) | 2016-06-02 | 2019-03-19 | Cloudbreak Therapeutics, Llc | composições e métodos para a utilização de nintedanib para melhorar o sucesso da cirurgia do glaucoma |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100185564A1 (en) * | 2009-01-21 | 2010-07-22 | Mccormick & Company, Inc. | Method and questionnaire for measuring consumer emotions associated with products |
| WO2013188268A1 (en) * | 2012-06-12 | 2013-12-19 | Bayer Healthcare Llc | Topical ophthalmological pharmaceutical composition containing pazopanib |
| US8747852B1 (en) * | 2012-12-28 | 2014-06-10 | Randal Tanh Hoang Pham | Methods of treating pterygium |
| CN108135737B (zh) * | 2015-06-06 | 2021-11-05 | 拨云生物医药科技(广州)有限公司 | 用于治疗翼状胬肉的组合物和方法 |
| EA035465B1 (ru) * | 2015-06-09 | 2020-06-22 | Байер Фарма Акциенгезельшафт | 7-замещенные 1-арил-нафтиридин-3-амиды карбоновой кислоты в качестве положительных аллостерических модуляторов мускаринового рецептора m2, способ их получения, их применение для лечения и/или профилактики заболеваний и лекарственное средство, содержащее эти соединения |
| TWI664965B (zh) * | 2015-06-22 | 2019-07-11 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物、其使用方法、及其製備方法 |
| CN108295072A (zh) * | 2015-12-09 | 2018-07-20 | 瑞阳(苏州)生物科技有限公司 | 尼达尼布防治眼部疾病的用途 |
| MX394623B (es) * | 2016-02-04 | 2025-03-24 | Ads Therapeutics Llc | Tecnología de sinergismo anticuerpo-fármaco para el tratamiento de enfermedades. |
| BR112018074450A2 (pt) * | 2016-06-02 | 2019-03-19 | Cloudbreak Therapeutics, Llc | composições e métodos para a utilização de nintedanib para melhorar o sucesso da cirurgia do glaucoma |
| US11278546B2 (en) * | 2016-07-22 | 2022-03-22 | Aiviva Biopharma, Inc. | Multikinase inhibitors and uses in ocular fibrosis |
| WO2018064354A1 (en) * | 2016-09-28 | 2018-04-05 | Medicon Pharmaceuticals, Inc. | Compositions and methods for treating ophthalmic conditions |
| JP7306697B2 (ja) * | 2017-03-14 | 2023-07-11 | オールジェネシス バイオセラピューティクス インコーポレイテッド | ３－ｚ－［１－（４－（ｎ－（（４－メチル－ピペラジン－１－イル）－メチルカルボニル）－ｎ－メチル－アミノ）－フェニルアミノ）－１－フェニル－メチレン］－６－メトキシカルボニル－２－インドリノンの結晶形 |
| KR20210013574A (ko) * | 2018-05-25 | 2021-02-04 | 클라우드브레이크 테라퓨틱스, 엘엘씨 | 안구 충혈 치료용 조성물 및 이를 사용하여 안구 충혈을 치료하는 방법 |
-
2020
- 2020-09-10 BR BR112021026662A patent/BR112021026662A2/pt unknown
- 2020-09-10 EP EP20863255.4A patent/EP4027997A4/en active Pending
- 2020-09-10 MX MX2022000468A patent/MX2022000468A/es unknown
- 2020-09-10 WO PCT/US2020/050150 patent/WO2021050692A2/en not_active Ceased
- 2020-09-10 JP JP2022507861A patent/JP2022547401A/ja active Pending
- 2020-09-10 CA CA3146811A patent/CA3146811A1/en active Pending
- 2020-09-10 AU AU2020346812A patent/AU2020346812A1/en not_active Abandoned
- 2020-09-10 KR KR1020227010256A patent/KR20220061147A/ko active Pending
- 2020-09-10 CN CN202080061833.2A patent/CN114340618A/zh active Pending
- 2020-09-10 US US17/640,889 patent/US20220331310A1/en active Pending
-
2026
- 2026-03-09 JP JP2026036757A patent/JP2026090631A/ja active Pending
- 2026-03-27 AU AU2026202351A patent/AU2026202351A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2731000C2 (ru) | Нейроактивные стероиды, композиции и способы их применения | |
| JP2021130687A (ja) | ガボキサドールでの発達障害の処置方法 | |
| CA3158448A1 (en) | Neuroactive steroids, compositions, and uses thereof | |
| US20140249166A1 (en) | Methods of treating patients suffering from movement disorders | |
| TW200402296A (en) | Combination of brimonidine and timolol for topical ophthalmic use | |
| JPH045648B2 (enExample) | ||
| US11723890B2 (en) | Methods of treatment using an mTORC1 modulator | |
| JP2019535760A (ja) | フルピルチンを用いた発達障害および／または発作性障害の処置方法 | |
| TW202112377A (zh) | 藉由jak抑制劑局部治療白斑症 | |
| JP6137833B2 (ja) | 脱髄性および他の神経系疾患を患っている患者における神経認知的および／または神経精神医学的障害を改善するための４−アミノピリジンの使用 | |
| JP2022545568A5 (enExample) | ||
| JP2002509104A (ja) | 遅発性ジスキネジア及び他の運動障害の治療方法 | |
| WO2020198039A1 (en) | Ketamine for treatment of sensory processing deficits | |
| AU2026202351A1 (en) | Methods for alleviating pterygium-associated worry about eye appearance | |
| WO2025188619A1 (en) | Methods of treating parkinson's disease with t-type calcium channel modulators | |
| Hass et al. | Comparison between pilocarpine and timolol on diurnal pressures in open-angle glaucoma | |
| JPH09278653A (ja) | 網膜疾患治療剤 | |
| RS60365B1 (sr) | Lečenje alopecije areate | |
| JP2022514659A (ja) | ドーパミン作動性ｃｎｓ障害の治療におけるｌｙ３１５４２０７の使用のための用量レジメン | |
| US20240408086A1 (en) | Use of luvadaxistat for the treatment of cognitive impairment | |
| CN115634226A (zh) | 一种采用长春西汀治疗近视的方法 | |
| RU2469734C2 (ru) | Лечебное средство для лечения расстройств аккомодаций "stiak" | |
| JP4234218B2 (ja) | 特定の神経運動障害および精神−知力障害の処置に有用な医薬組成物を得るためのスルブチアミンの用途 | |
| WO1995028934A2 (en) | Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers | |
| JP2020517681A (ja) | 中枢神経系の変性疾患及び／又はリソソーム蓄積疾患を予防及び／又は治療するための新規組成物 |